| Literature DB >> 35800114 |
Fangyou Lin1, Bojun Li1, Ting Rao1, Yuan Ruan1, Weimin Yu1, Fan Cheng1, Stéphane Larré2.
Abstract
Background: Fused renal pyramid (FRP) is a kidney anatomical structure which was first identified by us. The vascular anatomy of FRP exhibits different from that of the normal renal pyramid (NRP), manifested by the distribution of the ectopic interlobar arteries in FRP. In this study, we analyzed the effect of FRPs on bleeding when using calyx access in mini-percutaneous nephrolithotomy (PCNL). Patients andEntities:
Keywords: bleeding; calyx access; kidney anatomy; mini-PCNL; renal stones
Year: 2022 PMID: 35800114 PMCID: PMC9253458 DOI: 10.3389/fsurg.2022.942147
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1(A) FRP in a nephrectomy specimen. There are two papillae entering a compound calyx. The red circle indicates the FRP. (B) FRP in a human kidney. There are two renal pyramids fused into one FRP. The white arrow indicates the interlobar blood vessel distributed in the FRP. (C) NRP in a human kidney. The white arrow indicates the interlobar artery distributed in the renal column. FRP, fused renal pyramid; NRP, normal renal pyramid.
Figure 2Flow diagram of excluded and grouped patients. NRP, normal renal pyramid; FRP, fused renal pyramid.
Figure 3(A) NRP and the simple calyx in Doppler ultrasound. There are blood flow signals in the renal columns on either side of the NRP. The white arrow indicates the NRP. (B) Schematic representation of the axial puncture of the calyx corresponding to NRP. (C,D) FRP and the compound calyx in B-mode ultrasound and Doppler ultrasound. The white arrow indicates the FRP. Color flow signals exist within FRP. (E) Schematic representation of calyx puncture through the hypovascular area of the FRP. NRP, normal renal pyramid; FRP, fused renal pyramid.
Patients’ demographic, operative and postoperative clinical characteristics.
| Characteristics | Group A | Group B |
|
|---|---|---|---|
| Number of patients | 346 | 287 | |
| Age, years, mean (SD) | 55.6 (12.0) | 54.6 (11.7) | 0.292 |
| Gender-male/female, | 217/129 | 174/113 | 0.622 |
| Stone size-maximal diameter, cm | 2.07 (0.99) | 2.24 (1.05) | 0.037 |
| Laterality–left/right, | 178/168 | 151/136 | 0.811 |
| Stone type, | 0.226 | ||
| Single | 116 (33.5%) | 96 (33.4%) | |
| Multiple | 199 (57.5%) | 158 (55.1%) | |
| Staghorn | 31 (9.0%) | 33 (11.5%) | |
| Stone location, | 0.293 | ||
| Calyx | 159 (46.0%) | 126 (43.9%) | |
| Pelvis | 116 (33.5%) | 107 (37.3%) | |
| Upper ureter | 71 (20.5%) | 54 (18.8%) | |
| Grade of hydronephrosis, | 0.246 | ||
| None or mild | 183 (52.9%) | 146 (50.9%) | |
| Moderate | 71 (20.5%) | 77 (26.8%) | |
| Severe | 92 (26.6%) | 64 (22.3%) | |
| Comorbidities, | |||
| Hypertension | 110 (31.8%) | 113 (39.4%) | 0.186 |
| Diabetes mellitus | 33 (9.5%) | 38 (13.2%) | 0.164 |
| Hyperuricemia | 20 (5.8%) | 24 (8.4%) | 0.213 |
| Previous stone surgery | 108 (31.2%) | 107 (37.3%) | 0.110 |
| Preoperative serum creatinine level, µmol/L, mean (SD) | 82.8 (40.2) | 82.3 (40.5) | 0.787 |
| Puncture sites, | 0.285 | ||
| Upper calyx | 18 (5.2%) | 14 (4.9%) | |
| Middle calyx | 277 (80.1%) | 234 (81.5%) | |
| Lower calyx | 51 (14.7%) | 39 (13.6%) | |
| Tract size, | 0.236 | ||
| 16Fr | 54 (15.6%) | 60 (20.9%) | |
| 18Fr | 2 (0.6%) | 3 (1.0%) | |
| 20Fr | 255 (73.7%) | 206 (71.8%) | |
| 22Fr | 35 (10.1%) | 18 (6.3%) | |
| Postoperative serum creatinine level, µmol/L, mean (SD) | 84.6 (42.5) | 83.4 (41.2) | 0.472 |
| Hb drop, g/L, mean (SD) | 12.68 (9.80) | 12.07 (9.01) | 0.527 |
| Stone free after one stage operation, | 248 (71.7%) | 213 (74.2%) | 0.530 |
Hb, hemoglobin; SD, standard deviation.
Comparison of postoperative complications stratified according to puncture method, N (%).
| Complications | Clavien–Dindo grade | Group A | Group B |
|
|---|---|---|---|---|
| Persistent pain | I | 7 (2.0%) | 8 (2.8%) | 0.604 |
| Hydrothorax | I | 6 (1.7%) | 7 (2.4%) | 0.582 |
| Subcapsular haematoma | II | 17 (4.9%) | 13 (4.5%) | 0.853 |
| Blood transfusion | II | 18 (5.2%) | 3 (1.0%) | 0.003 |
| Angioembolisation | IIIb | 8 (2.3%) | 1 (0.35%) | 0.045 |
| Fever (>38.5°C) | I | 20 (5.8%) | 14 (4.9%) | 0.724 |
| Urosepsis | IVa | 9 (2.6%) | 11 (3.8%) | 0.495 |
| Septic shock | IVb | 5 (1.4%) | 0 | / |
| Overall complications | I–II | 35 (10.1%) | 27 (9.4%) | 0.790 |
| IIIb–IVb | 20 (5.8%) | 13 (4.5%) | 0.591 |